Structural Adaptation of the Single-Stranded DNA-Binding Protein C-Terminal to DNA Metabolizing Partners Guides Inhibitor Design.
Attila TököliBrigitta BodnárFerenc BogárGabor ParagiAnasztázia HetényiÉva BartusEdit WéberZsófia HegedüsZoltan SzaboGábor KecskemétiGerda SzakonyiTamás A MartinekPublished in: Pharmaceutics (2023)
Single-stranded DNA-binding protein (SSB) is a bacterial interaction hub and an appealing target for antimicrobial therapy. Understanding the structural adaptation of the disordered SSB C-terminus (SSB-Ct) to DNA metabolizing enzymes (e.g., ExoI and RecO) is essential for designing high-affinity SSB mimetic inhibitors. Molecular dynamics simulations revealed the transient interactions of SSB-Ct with two hot spots on ExoI and RecO. The residual flexibility of the peptide-protein complexes allows adaptive molecular recognition. Scanning with non-canonical amino acids revealed that modifications at both termini of SSB-Ct could increase the affinity, supporting the two-hot-spot binding model. Combining unnatural amino acid substitutions on both segments of the peptide resulted in enthalpy-enhanced affinity, accompanied by enthalpy-entropy compensation, as determined by isothermal calorimetry. NMR data and molecular modeling confirmed the reduced flexibility of the improved affinity complexes. Our results highlight that the SSB-Ct mimetics bind to the DNA metabolizing targets through the hot spots, interacting with both of segments of the ligands.
Keyphrases
- binding protein
- circulating tumor
- amino acid
- cell free
- single molecule
- nucleic acid
- molecular dynamics simulations
- computed tomography
- image quality
- dual energy
- contrast enhanced
- high resolution
- positron emission tomography
- magnetic resonance
- single cell
- molecular docking
- cell therapy
- stem cells
- electronic health record
- capillary electrophoresis
- machine learning
- big data
- human immunodeficiency virus
- mass spectrometry
- artificial intelligence
- replacement therapy
- protein kinase
- blood brain barrier
- transcription factor
- dna binding
- hepatitis c virus